Jonathan A Bernstein Selected Research

Histamine Antagonists (Antihistamines)

1/2022	An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
1/2022	The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review.
1/2020	Making the GRADE in anaphylaxis management: Toward recommendations integrating values, preferences, context, and shared decision making.
1/2020	Current and Future Treatments of Rhinitis and Sinusitis.
1/2020	Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis.
1/2019	Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.
7/2018	Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.
12/2017	Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.
1/2017	Therapy of antihistamine-resistant chronic spontaneous urticaria.
9/2016	Guideline of Chronic Urticaria Beyond.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan A Bernstein Research Topics

Disease

49	Hereditary Angioedemas 01/2022 - 01/2008
37	Asthma (Bronchial Asthma) 12/2022 - 08/2002
36	Angioedema 01/2022 - 01/2008
26	Hypersensitivity (Allergy) 07/2022 - 01/2003
21	Urticaria (Hives) 05/2022 - 01/2004
20	Chronic Urticaria 01/2022 - 08/2002
20	Rhinitis 01/2020 - 03/2002
17	Anaphylaxis (Anaphylactic Shock) 01/2022 - 04/2011
8	Allergic Rhinitis 11/2016 - 03/2002
7	Neurodevelopmental Disorders 01/2022 - 01/2016
7	Vasomotor Rhinitis 01/2017 - 10/2007
6	Intellectual Disability (Idiocy) 01/2022 - 10/2016
6	Inborn Genetic Diseases (Disease, Hereditary) 02/2021 - 01/2013
4	Rare Diseases (Rare Disease) 01/2022 - 01/2008
4	Seizures (Absence Seizure) 01/2020 - 10/2014
4	Autoimmune progesterone dermatitis 01/2020 - 04/2011
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 03/2011
4	Neoplasms (Cancer) 01/2017 - 08/2002
4	Edema (Dropsy) 04/2015 - 08/2010
3	Cough 05/2022 - 01/2017
3	Rhinosinusitis 01/2022 - 02/2007
3	Undiagnosed Diseases 01/2021 - 11/2018
3	Microcephaly 10/2017 - 10/2014
3	Timothy syndrome 01/2017 - 03/2011
3	Respiratory Hypersensitivity 05/2014 - 04/2005
3	Acquired angioedema 01/2014 - 08/2002
2	Chronic Cough 05/2022 - 12/2021
2	COVID-19 02/2022 - 05/2020
2	Vomiting 01/2021 - 10/2009
2	Epilepsy (Aura) 11/2020 - 01/2016
2	Wounds and Injuries (Trauma) 10/2020 - 10/2010
2	Occupational Asthma 08/2020 - 11/2011
2	Obesity 01/2020 - 06/2012
2	Dermatitis 01/2020 - 04/2011
2	Prekallikrein Deficiency 01/2020 - 09/2019
2	Inflammation (Inflammations) 09/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

22	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 10/2009
18	Omalizumab (Xolair)FDA Link 01/2022 - 09/2015
15	Histamine Antagonists (Antihistamines)IBA 01/2022 - 03/2002
15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2007
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
14	Immunoglobulin E (IgE)IBA 01/2022 - 06/2003
14	BradykininIBA 04/2021 - 01/2008
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
10	Pharmaceutical PreparationsIBA 11/2020 - 01/2008
8	Plasma KallikreinIBA 01/2021 - 01/2010
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020 - 05/2013
7	AllergensIBA 07/2022 - 11/2015
7	Irritants (Vesicants)IBA 02/2022 - 06/2009
7	azelastine (Optivar)FDA LinkGeneric 01/2017 - 10/2007
7	ecallantide FDA Link 04/2016 - 01/2010
6	Biological ProductsIBA 10/2020 - 01/2017
6	Tiotropium Bromide (Spiriva)FDA Link 09/2019 - 01/2017
6	icatibantIBA 11/2017 - 01/2008
5	lanadelumabIBA 01/2022 - 01/2017
5	Progesterone FDA LinkGeneric 01/2020 - 04/2011
5	Methacholine Chloride (Methacholine)FDA Link 10/2016 - 11/2009
4	Monoclonal AntibodiesIBA 01/2022 - 09/2016
4	GlucocorticoidsIBA 01/2022 - 01/2014
4	Histamine (Histamine Dihydrochloride)FDA Link 04/2021 - 11/2012
4	ChromatinIBA 01/2021 - 10/2014
4	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020 - 11/2012
4	Progestins (Progestagens)IBA 01/2020 - 05/2017
4	Environmental Pollutants (Pollutants, Environmental)IBA 11/2013 - 03/2009
4	Nasal SpraysIBA 08/2011 - 01/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 11/2009
3	PrekallikreinIBA 01/2022 - 09/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 02/2007
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
3	CytokinesIBA 12/2021 - 10/2010
3	benralizumabIBA 01/2021 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 08/2002
3	AntibodiesIBA 01/2019 - 11/2011
3	Arginine (L-Arginine)FDA Link 01/2018 - 10/2016
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2017 - 10/2007
3	Capsaicin (Zostrix)FDA Link 05/2014 - 08/2011
3	Bronchodilator Agents (Bronchodilators)IBA 05/2014 - 11/2009
3	Seminal Plasma ProteinsIBA 09/2011 - 01/2003
2	ligelizumabIBA 01/2022 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2009
2	Cetirizine (Zyrtec)FDA LinkGeneric 01/2022 - 01/2004
2	Histones (Histone)IBA 01/2022 - 01/2016
2	Ion Channels (Ion Channel)IBA 12/2021 - 01/2014
2	EnzymesIBA 01/2021 - 05/2015
2	Transaminases (Aminotransferases)IBA 11/2020 - 10/2014
2	dupilumabIBA 01/2020 - 01/2019
2	Contraceptive Agents (Contraceptives)IBA 01/2020 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2016
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2019 - 01/2004

Therapy/Procedure

51	Therapeutics 12/2022 - 01/2004
4	Drug Therapy (Chemotherapy) 05/2022 - 08/2002
4	Immunotherapy 01/2022 - 01/2011
3	Premedication 07/2022 - 01/2020
3	Precision Medicine 10/2020 - 01/2018
3	Biological Therapy 07/2020 - 01/2019
3	Aftercare (After-Treatment) 04/2016 - 10/2009
2	Genomic Medicine 01/2021 - 10/2019
2	Condoms (Condom) 10/2020 - 09/2011
2	Injections 01/2020 - 08/2010